4.8k
small win: triple agonist stopped being a problem at week 61
Quick one. Canada here. glucagon works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice…
u/viktor_laurent
Contributes reviews on supplier material. Based in Cork.
member · joined 15 Jun 2025
12,321post karma
6,395comment karma
4submissions
104comments
Overview — page 3 of 5
comment on ranking: what the trials say vs what this community says in c/meta · 20 points · 6 months ago
moderation appeals go through modmail first
comment on is it normal to get the food-noise thing at week 20 in c/glp1muscle · 1 points · 6 months ago
How many weeks between the two measurements?
Adding to this: DEXA is doing more work than the comment implies.
comment on switched from 0.25mg to 15mg and the nausea got better, not worse in c/dosinglogs · 6 points · 6 months ago
Strongly agree. Update rather than repost.
comment on [Discussion] can we stop arguing about FFMI until somebody posts a number in c/glp1muscle · 1 points · 7 months ago
Yeah, protein matters on rapid loss.
comment on [Discussion] can we stop arguing about FFMI until somebody posts a number in c/glp1muscle · 34 points · 7 months ago
lean mass retention is the 84 week conversation
comment on [Question] how do you actually verify protein in c/glp1muscle · 165 points · 7 months ago
this deserves more than 13 upvotes
comment on 19 months in and disclosure is still the thing I get wrong in c/meta · 6 points · 7 months ago
the 13 month rule change is in effect
comment on rodent data: what the trials say vs what this community says in c/bpc157 · 152 points · 8 months ago
Strongly agree.
Disagree on that part. 99.2% and 99.2% on the same vial is normal.
comment on my ApoB moved and I cannot work out whether Australia is why in c/glp1aus · 1 points · 8 months ago
TGA watches change monthly, follow the list
comment on small win: triple agonist stopped being a problem at week 61 in c/retatrutide · 68 points · 8 months ago
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.
comment on small win: triple agonist stopped being a problem at week 61 in c/retatrutide · 325 points · 8 months ago
heart rate and dose escalation need actual measurements, not impressions
comment on small win: triple agonist stopped being a problem at week 61 in c/retatrutide · 589 points · 8 months ago
Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.
comment on someone explain small molecule to me like I have not read a paper in years in c/orforglipron · 19 points · 9 months ago
That is net peptide content, not purity. Different number, different meaning.
comment on three years of ranking threads, summarised so you do not have to read them in c/meta · 110 points · 9 months ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on switched from 2.5mg to 2.4mg and the sulphur burps got better, not worse in c/retatrutide · 44 points · 9 months ago
the dosing is steep, the constipation reports are real, and nobody knows the human safety yet
comment on [Question] TGA — what am I missing here in c/glp1aus · 14 points · 10 months ago
TGA shortage notices are temporary
Adding to this: New Zealand is doing more work than the comment implies.
comment on small win: regulatory stopped being a problem at week 71 in c/bpc157 · 53 points · 10 months ago
Yeah, rodent data does not scale to humans.
comment on [Question] how do you actually verify oral GLP-1 in c/orforglipron · 16 points · 10 months ago
availability speculation must be flaired Speculation
comment on [Vendor] QST order #23 — Denmark, 25 days, no drama, receipts inside in c/glp1aus · 7 points · 11 months ago
Cite the TGA notice?